Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-15 Option Award | 2022-06-17 4:24 pm | N/A 2032-06-14 | Acumen Pharmaceuticals Inc. | ABOS | Sevigny Jeffrey Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:19 pm | N/A 2031-06-30 | Acumen Pharmaceuticals Inc. | ABOS | Sevigny Jeffrey Director | 34,000 | $0 | 34,000 (Direct) | View |
Ownership | 2021-06-30 6:58 pm | N/A 2029-03-01 | Acumen Pharmaceuticals Inc. | ABOS | Sevigny Jeffrey Director | 0 | $0 | 49,778 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:09 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Sevigny Jeffrey Chief Medical Officer | 611,781 | $0 | 0 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:49 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Sevigny Jeffrey Chief Medical Officer | 89,000 | $0 | 89,000 (Direct) | View |
Ownership | 2019-06-19 6:29 pm | N/A 2028-03-05 | Prevail Therapeutics Inc. | PRVL | Sevigny Jeffrey Chief Medical Officer | 0 | $0 | 522,781 (Direct) | View |